199 related articles for article (PubMed ID: 37294090)
1. Mild SARS-CoV-2 infection results in long-lasting microbiota instability.
Upadhyay V; Suryawanshi RK; Tasoff P; McCavitt-Malvido M; Kumar RG; Murray VW; Noecker C; Bisanz JE; Hswen Y; Ha CWY; Sreekumar B; Chen IP; Lynch SV; Ott M; Lee S; Turnbaugh PJ
mBio; 2023 Aug; 14(4):e0088923. PubMed ID: 37294090
[TBL] [Abstract][Full Text] [Related]
2. Mild SARS-CoV-2 infection results in long-lasting microbiota instability.
Upadhyay V; Suryawanshi R; Tasoff P; McCavitt-Malvido M; Kumar GR; Murray VW; Noecker C; Bisanz JE; Hswen Y; Ha C; Sreekumar B; Chen IP; Lynch SV; Ott M; Lee S; Turnbaugh PJ
bioRxiv; 2022 Dec; ():. PubMed ID: 36523400
[TBL] [Abstract][Full Text] [Related]
3. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
[TBL] [Abstract][Full Text] [Related]
4. Altered gut microbiota composition in children and their caregivers infected with the SARS-CoV-2 Omicron variant.
Wang YZ; Zhou JG; Lu YM; Hu H; Xiao FF; Ge T; Wang X; Zheng L; Yu LH; Le J; Yu H; Yu GJ; Xia Q; Zhang T; Zhou WH
World J Pediatr; 2023 May; 19(5):478-488. PubMed ID: 36627507
[TBL] [Abstract][Full Text] [Related]
5. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
6. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters.
Sencio V; Machelart A; Robil C; Benech N; Hoffmann E; Galbert C; Deryuter L; Heumel S; Hantute-Ghesquier A; Flourens A; Brodin P; Infanti F; Richard V; Dubuisson J; Grangette C; Sulpice T; Wolowczuk I; Pinet F; Prévot V; Belouzard S; Briand F; Duterque-Coquillaud M; Sokol H; Trottein F
Gut Microbes; 2022; 14(1):2018900. PubMed ID: 34965194
[TBL] [Abstract][Full Text] [Related]
7. Roles of the gut microbiota in severe SARS-CoV-2 infection.
Liu Y; Kuang D; Li D; Yang J; Yan J; Xia Y; Zhang F; Cao H
Cytokine Growth Factor Rev; 2022 Feb; 63():98-107. PubMed ID: 35131164
[TBL] [Abstract][Full Text] [Related]
8. Mild and Severe SARS-CoV-2 Infection Induces Respiratory and Intestinal Microbiome Changes in the K18-hACE2 Transgenic Mouse Model.
Seibert B; Cáceres CJ; Cardenas-Garcia S; Carnaccini S; Geiger G; Rajao DS; Ottesen E; Perez DR
Microbiol Spectr; 2021 Sep; 9(1):e0053621. PubMed ID: 34378965
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
[TBL] [Abstract][Full Text] [Related]
10. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV.
Ishizaka A; Koga M; Mizutani T; Yamayoshi S; Iwatsuki-Horimoto K; Adachi E; Suzuki Y; Kawaoka Y; Yotsuyanagi H
BMC Microbiol; 2024 Jan; 24(1):6. PubMed ID: 38172680
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications.
Zhang F; Lau RI; Liu Q; Su Q; Chan FKL; Ng SC
Nat Rev Gastroenterol Hepatol; 2023 May; 20(5):323-337. PubMed ID: 36271144
[TBL] [Abstract][Full Text] [Related]
12. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
Xiang H; Liu QP
World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Three Variants of SARS-CoV-2 In Vivo Shows Host-Dependent Pathogenicity in Hamsters, While Not in K18-hACE2 Mice.
Toomer G; Burns W; Garcia L; Henry G; Biancofiori A; George A; Duffy C; Chu J; Sides M; Muñoz M; Garcia K; Nikolai-Yogerst A; Peng X; Westfall L; Baker R
Viruses; 2022 Nov; 14(11):. PubMed ID: 36423193
[TBL] [Abstract][Full Text] [Related]
14. Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection.
Li J; Jing Q; Li J; Hua M; Di L; Song C; Huang Y; Wang J; Chen C; Wu AR
Microbiome; 2023 Mar; 11(1):38. PubMed ID: 36869345
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of ACE, AGTR1, and ACE2 genes mediating SARS-CoV-2 pathogenesis by gut microbiota members and their postbiotics on Caco-2 cells.
Ahmadi Badi S; Malek A; Paolini A; Rouhollahi Masoumi M; Seyedi SA; Amanzadeh A; Masotti A; Khatami S; Siadat SD
Microb Pathog; 2022 Dec; 173(Pt A):105798. PubMed ID: 36174833
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Omicron (B.1.1.529) shows minimal neurotropism in a double-humanized mouse model.
Alves RPDS; Wang YT; Mikulski Z; McArdle S; Shafee N; Valentine KM; Miller R; Verma SK; Batiz FAS; Maule E; Nguyen MN; Timis J; Mann C; Zandonatti M; Alarcon S; Rowe J; Kronenberg M; Weiskopf D; Sette A; Hastie K; Saphire EO; Festin S; Kim K; Shresta S
Antiviral Res; 2023 Apr; 212():105580. PubMed ID: 36940916
[TBL] [Abstract][Full Text] [Related]
17. Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity.
Zuo T; Liu Q; Zhang F; Yeoh YK; Wan Y; Zhan H; Lui GCY; Chen Z; Li AYL; Cheung CP; Chen N; Lv W; Ng RWY; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Microbiome; 2021 Apr; 9(1):91. PubMed ID: 33853691
[TBL] [Abstract][Full Text] [Related]
18. Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome.
Wang Y; Wu G; Zhao L; Wang W
mBio; 2022 Apr; 13(2):e0380121. PubMed ID: 35254129
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms.
Mendes de Almeida V; Engel DF; Ricci MF; Cruz CS; Lopes ÍS; Alves DA; d' Auriol M; Magalhães J; Machado EC; Rocha VM; Carvalho TG; Lacerda LSB; Pimenta JC; Aganetti M; Zuccoli GS; Smith BJ; Carregari VC; da Silva Rosa E; Galvão I; Dantas Cassali G; Garcia CC; Teixeira MM; André LC; Ribeiro FM; Martins FS; Saia RS; Costa VV; Martins-de-Souza D; Hansbro PM; Marques JT; Aguiar ERGR; Vieira AT
Gut Microbes; 2023 Dec; 15(2):2249146. PubMed ID: 37668317
[TBL] [Abstract][Full Text] [Related]
20. Exploring gut-lung axis crosstalk in SARS-CoV-2 infection: Insights from a hACE2 mouse model.
Zhang Y; Ma Y; Sun W; Zhou X; Wang R; Xie P; Dai L; Gao Y; Li J
J Med Virol; 2024 Jan; 96(1):e29336. PubMed ID: 38193530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
